Bliss GVS Pharma Share Price

₹ 631.30

+₹14.10 (2.28%)
1D
Last updated 03 Nov, 2026, 15:59 IST
NSE: BLISSGVS
|
Pharmaceuticals

Bliss GVS Pharma Share Price Today

As of 3 Nov 2026, Bliss GVS Pharma share price is ₹631.30. The stock opened at ₹618.00, compared to its previous close of ₹617.20. During today's trading session, Bliss GVS Pharma share price moved in the range of ₹618.00 to ₹642.00, with an average price of ₹630.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹118.00 and a high of ₹739.90.

Share price over the last 1 day fell from 630.00 to 625.00, ranging between 622.00 and 642.00.
₹618.00
2.28% up today
₹642.00
1D LOW
1D HIGH

Bliss GVS Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 67.92% QoQ
Latest Earning
Net Profit TrendUp by 38.84% QoQ
Latest Earning
Revenue TrendUp by 10.08% QoQ
Stock Performance
OutperformingBeat Nifty by 44.51 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 43.01%
Shareholding Pattern
DIIDII increased stake by 4.45%
Shareholding Pattern
FIIFII decreased stake by 37.71%
Bliss GVS Pharma stock performance
Open₹618.00
High₹642.00
Low₹618.00
Prev. close₹617.20
Bliss GVS Pharma trading activity
Volume58,864
Average traded price₹635.52
Last traded time03:59:38 03 Nov
Last traded quantity5
Circuit
L
H
₹586.35
₹648.05
52-week
L
H
₹118.00
₹739.90
Mkt Cap Cr
6,560.17
P/E
39.4
P/B
5.08
ROA
10.52%
ROE
12.49%
ROCE
18.55%
Quick Ratio
3.38
EV/EBITDA
24.04

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Bliss GVS Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Bliss GVS Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Bliss GVS Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Bliss GVS Pharma Company Background

ISIN
INE416D01022
Sector Market Cap
₹ 6,560.17 Cr

Bliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.

Bliss GVS Pharma Financial Highlights

  • Revenue: Bliss GVS Pharma reported revenue of ₹1,000.64 crore in FY26 vs ₹846.22 crore in FY25. It showed an increase of 18.25% on a yearly basis.
  • Operating Profit: Bliss GVS Pharma reported an operating profit of ₹189.59 crore in FY26 vs ₹125.64 crore in FY25. It showed an increase of 50.90% on a year-on-year basis.
  • Net Profit: Bliss GVS Pharma reported a net profit of ₹134.73 crore in FY26 vs ₹90.26 crore in FY25. It showed an increase of 49.27% on a yearly basis.

Bliss GVS Pharma Quarterly Result Highlights

  • Bliss GVS Pharma reported revenue of ₹295.18 crore in Jun 2026, compared with ₹268.15 crore in Mar 2026, representing an increase of 10.08% on a quarter-on-quarter (QoQ) basis.
  • Bliss GVS Pharma reported an operating profit of ₹75.48 crore in Jun 2026, compared with ₹44.95 crore in Mar 2026, representing an increase of 67.92% on a quarter-on-quarter (QoQ) basis.
  • Bliss GVS Pharma reported a profit of ₹51.37 crore in Jun 2026, compared with ₹37.00 crore in Mar 2026, reflecting an increase of 38.84% on a QoQ basis.
  • The earnings per share (EPS) of Bliss GVS Pharma stood at ₹12.23 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
50.07%
FII
5.03%
Other DII
9.62%
Retail and other
35.28%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202514.54%
Mar 202610.45%
Jun 20268.07%
Sep 20265.03%

Bliss GVS Pharma Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Bliss GVS Pharma Share Price History

Bliss GVS Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹620.00 / ₹617.20
-4.68%
30 Oct 26
₹660.00 / ₹647.50
-4.91%
29 Oct 26
₹667.95 / ₹680.90
+5.00%
28 Oct 26
₹642.00 / ₹648.50
+1.45%
Show more

Bliss GVS Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹927.11₹809.73₹770.24₹751.59
Other Income₹73.53₹36.49₹28.74₹17.79
Total Revenue₹1,000.64₹846.22₹798.98₹769.37
Total Expenses₹808.57₹720.58₹652.91₹663.30
Profit Before Tax₹189.59₹125.64₹116.87₹106.07
Tax₹54.86₹35.38₹35.29₹29.34
Profit After Tax₹134.73₹90.26₹81.58₹76.73
EPS - Basic₹12.23₹8.02₹7.23₹6.83
EPS - Diluted₹12.00₹7.95₹7.11₹6.72

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹189.59₹125.64₹146.07₹106.07
Income before WC changes₹285.46₹196.38₹184.24₹163.99
Change in Assets-₹158.32-₹53.98-₹35.62-₹75.86
Change in Liabilities₹53.88₹2.52-₹10.95-₹9.26
Change in WC-₹104.45-₹51.46-₹46.57-₹85.12
Cash flow from Operations₹138.72₹105.91₹102.82₹34.31
Cash flow from Investing-₹38.28-₹75.59-₹83.19-₹7.75
Cash flow from Financing-₹89.21-₹30.20-₹20.89-₹24.94
Total Cash Flow₹11.23₹0.13-₹1.27₹1.62
Cash (Start of the year)₹23.82₹23.59₹25.01₹21.99
Cash (End of the year)₹35.14₹23.82₹23.59₹25.01

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹546.08₹477.46₹400.72₹459.49
Current Assets₹946.34₹823.83₹810.87₹697.37
Total Assets₹1,492.41₹1,301.29₹1,211.59₹1,156.85
Current Liabilities₹235.54₹172.16₹157.41₹193.26
Net Current Asset₹710.79₹651.67₹653.47₹504.11
Non-Current Liabilities₹25.11₹37.28₹51.20₹46.17
Equity Capital₹1,231.76₹1,091.85₹1,002.98₹917.42
Total Equity & Liabilities₹1,492.41₹1,301.29₹1,211.59₹1,156.85

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹729.81₹667.20₹605.46₹598.34
Other Income₹43.72₹36.22₹33.50₹50.77
Total Revenue₹773.53₹703.42₹638.96₹649.11
Total Expenses₹637.91₹609.25₹527.62₹533.41
Profit Before Tax₹133.46₹94.17₹70.26₹115.69
Tax₹36.59₹25.20₹19.61₹30.21
Profit After Tax₹96.87₹68.97₹50.64₹85.48
EPS - Basic₹9.17₹6.56₹4.85₹8.23
EPS - Diluted₹9.00₹6.50₹4.77₹8.10

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹133.46₹94.17₹111.34₹115.69
Income before WC changes₹203.80₹150.61₹155.59₹157.11
Change in Assets-₹82.79-₹23.72-₹31.70-₹67.36
Change in Liabilities₹40.61₹0.64-₹12.38-₹8.23
Change in WC-₹42.18-₹23.08-₹44.08-₹75.58
Cash flow from Operations₹123.16₹97.21₹82.17₹43.81
Cash flow from Investing-₹51.40-₹77.87-₹65.84-₹12.97
Cash flow from Financing-₹75.37-₹26.56-₹20.76-₹26.05
Total Cash Flow-₹3.61-₹7.23-₹4.43₹4.79
Cash (Start of the year)₹6.85₹14.17₹18.60₹13.82
Cash (End of the year)₹3.33₹6.85₹14.17₹18.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹517.82₹454.40₹378.04₹410.04
Current Assets₹826.36₹765.74₹772.23₹729.65
Total Assets₹1,344.18₹1,220.14₹1,150.27₹1,139.69
Current Liabilities₹168.59₹125.00₹114.89₹153.36
Net Current Asset₹657.77₹640.74₹657.34₹576.30
Non-Current Liabilities₹20.40₹36.51₹46.94₹49.34
Equity Capital₹1,155.19₹1,058.63₹988.44₹937.00
Total Equity & Liabilities₹1,344.18₹1,220.14₹1,150.27₹1,139.69
* All values are in INR Crore
Bliss GVS Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
10631.300
0000
0000
0000
0000
Total bid quantity10
Total ask quantity0
Bliss GVS Pharma technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
43.07
Neutral
ATR (14)
30.87
Neutral
STOCH(9,6)
23.89
Neutral
STOCH RSI (14)
28.26
Neutral
ADX(9)
24.97
Bearish
UO(9)
47.92
Neutral
ROC(12)
-6.58
Bearish
WillR(14)
-76.11
Neutral
Period
Simple value
Exponential vaue
5D
646.67
639.46
10D
635.86
642.75
20D
650.64
649.22
50D
655.26
631.57
100D
572.04
567.46
Volume trend — traded volume by day
3 Nov0L
2 Nov1L
30 Oct4L
29 Oct4L
28 Oct1L
27 Oct0L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Bliss GVS Pharma
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Bliss GVS Pharma

Fund name
AUM
Bandhan BSE Healthcare Index Fund
0.10%

Bliss GVS Pharma Returns Calculator

Ex-date: 08 Jul 2026
Ex-date: 18 Feb 2026

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Bliss GVS Pharma Share Price FAQs

Please be aware that Bliss GVS Pharma stock prices are subject to continuous fluctuations due to various factors.